Research Site

Manchester, New Hampshire 03103

1 studies enrolling now · 3 studies all time

What they study most

Anemia, Breast Cancer, Breast Cancer, Early Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
• Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy — Stopped early